Study Links Wegovy to Elevated Risk of Rare Eye Condition That Can Cause Vision Loss
A new analysis of FDA side-effect reports is raising questions about the safety profile of Wegovy, the popular weight-loss medication.
Researchers examined millions of reports in the FDA's adverse event database and found that Wegovy showed a risk signal for non-arteritic anterior ischemic optic neuropathy (NAION) — commonly referred